Skip to Content Skip to Content
Articles from Karen Kreeger
Two Penn Professors Named National Academy of Inventors Fellows

Two Penn Professors Named National Academy of Inventors Fellows

Professors James Eberwine, of the University of Pennsylvania’s Perelman School of Medicine and Shu Yang, of Penn’s School of Engineering and Applied Science, have been

Karen Kreeger , Evan Lerner

Penn Researchers Tame the Inflammatory Response in Kidney Dialysis

Penn Researchers Tame the Inflammatory Response in Kidney Dialysis

Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States. But it can also cause systemic inflammation, leading to complications such as cardiovascular disease and anemia, and patients who rely on the therapy have a five-year survival rate of only 35 percent.

Karen Kreeger

Penn Study Points to New Therapeutic Strategy in Chronic Kidney Disease

Penn Study Points to New Therapeutic Strategy in Chronic Kidney Disease

Chronic kidney disease (CKD) affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease’s progress towards kidney failure.

Karen Kreeger

Penn Researchers Unwind the Mysteries of the Cellular Clock

Penn Researchers Unwind the Mysteries of the Cellular Clock

Human existence is basically circadian. Most of us wake in the morning, sleep in the evening, and eat in between. Body temperature, metabolism, and hormone levels all fluctuate throughout the day, and it is increasingly clear that disruption of those cycles can lead to metabolic disease.

Karen Kreeger

Classification of Gene Mutations in a Children's Cancer May Point to Improved Treatments

Classification of Gene Mutations in a Children's Cancer May Point to Improved Treatments

Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations. Removing some of the guesswork in diagnosis and treatment, the researchers say, may lead to more successful outcomes for children with this often-deadly cancer.

Karen Kreeger

See-Through, One-Atom-Thick, Carbon Electrodes are a Powerful Tool for Studying Epilepsy, Other Brain Disorders, Penn Study Finds

See-Through, One-Atom-Thick, Carbon Electrodes are a Powerful Tool for Studying Epilepsy, Other Brain Disorders, Penn Study Finds

Researchers from the Perelman School of Medicine and School of Engineering at the University of Pennsylvania and The Children's Hospital of Philadelphia have used graphene -- a two-dimensional form of carbon only one atom thick -- to fabricate a

Karen Kreeger

Penn Medicine: New Gene Therapy for "Bubble Boy" Disease Appears to be Safe, Effective

Penn Medicine: New Gene Therapy for "Bubble Boy" Disease Appears to be Safe, Effective

A new form of gene therapy for boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a life-threatening condition also known as “bubble boy” disease, appears to be both effective and safe, according to an international clinical trial with sites in Boston, Cincinnati, Los Angeles, London, and Paris. 

Karen Kreeger

Load More